Cargando…

Sensitivity of (18)F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer

OBJECTIVES: Whole body [(18)F]-fluorodihydrotestosterone positron emission tomography ([(18)F]FDHT PET) imaging directly targets the androgen receptor and is a promising prognostic and predictive biomarker in metastatic castration-resistant cancer (mCRPC). To optimize [(18)F]FDHT PET-CT for diagnost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cysouw, Matthijs C. F., Kramer, Gerbrand M., Heijtel, Dennis, Schuit, Robert C., Morris, Michael J., van den Eertwegh, Alfons J. M., Voortman, Jens, Hoekstra, Otto S., Oprea-Lager, Daniela E., Boellaard, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667590/ https://www.ncbi.nlm.nih.gov/pubmed/31363939 http://dx.doi.org/10.1186/s13550-019-0531-8

Ejemplares similares

Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis
por: Cysouw, Matthijs C. F., et al.
Publicado: (2017)

A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems
por: Oprea-Lager, Daniela E., et al.
Publicado: (2015)

Dual-Phase PET-CT to Differentiate [(18)F]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate Cancer
por: Oprea-Lager, Daniela E., et al.
Publicado: (2012)

Machine learning-based analysis of [(18)F]DCFPyL PET radiomics for risk stratification in primary prostate cancer
por: Cysouw, Matthijs C. F., et al.
Publicado: (2020)

Optimization and validation of (18)F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer
por: Luining, Wietske I., et al.
Publicado: (2023)

Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer
por: Luining, Wietske I., et al.
Publicado: (2022)

Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics
por: Cysouw, M. C. F., et al.
Publicado: (2019)

Quantitative implications of the updated EARL 2019 PET–CT performance standards
por: Kaalep, Andres, et al.
Publicado: (2019)

Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images
por: Jauw, Yvonne W. S., et al.
Publicado: (2018)

Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
por: Eertink, Jakoba J., et al.
Publicado: (2022)

Impact of PET/CT system, reconstruction protocol, data analysis method, and repositioning on PET/CT precision: An experimental evaluation using an oncology and brain phantom
por: Mansor, Syahir, et al.
Publicado: (2017)

Repeatability of [(18)F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
por: Kolinger, Guilherme D., et al.
Publicado: (2019)

Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation
por: van Velden, Floris H. P., et al.
Publicado: (2016)

Diagnostic Performance of [(18)F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer
por: Iqbal, Ramsha, et al.
Publicado: (2021)

Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography
por: Oprea-Lager, Daniela E., et al.
Publicado: (2021)

Updating PET/CT performance standards and PET/CT interpretation criteria should go hand in hand
por: Boellaard, Ronald, et al.
Publicado: (2019)

Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET
por: Pfaehler, Elisabeth, et al.
Publicado: (2021)

Partial volume correction strategies for quantitative FDG PET in oncology
por: Hoetjes, Nikie J., et al.
Publicado: (2010)

Semi-quantitative cerebral blood flow parameters derived from non-invasive [(15)O]H(2)O PET studies
por: Koopman, Thomas, et al.
Publicado: (2017)

(89)Zr-cetuximab PET imaging in patients with advanced colorectal cancer
por: Menke-van der Houven van Oordt, Catharina Willemien, et al.
Publicado: (2015)

PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability
por: Pfaehler, Elisabeth, et al.
Publicado: (2020)

Classification of negative and positive (18)F-florbetapir brain PET studies in subjective cognitive decline patients using a convolutional neural network
por: de Vries, Bart Marius, et al.
Publicado: (2020)

3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body (18)F-Fluorodeoxyglucose and (89)Zr-Rituximab PET Scans
por: de Vries, Bart M., et al.
Publicado: (2022)

Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer (18)F-FDG PET Radiomics
por: Kolinger, Guilherme D., et al.
Publicado: (2022)

Metabolically active tumour volume segmentation from dynamic [(18)F]FLT PET studies in non-small cell lung cancer
por: Hoyng, Lieke L, et al.
Publicado: (2015)

Detection of prostate cancer with (18)F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial
por: Bodar, Y. J. L., et al.
Publicado: (2020)

Impact of [(18)F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology
por: Cheebsumon, Patsuree, et al.
Publicado: (2011)

Guidelines for quality control of PET/CT scans in a multicenter clinical study
por: Hristova, Ivalina, et al.
Publicado: (2017)

Pelvic lymph-node staging with (18)F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -
por: Jansen, B. H. E., et al.
Publicado: (2020)

Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis
por: Cheebsumon, Patsuree, et al.
Publicado: (2011)

Convolutional neural networks for automatic image quality control and EARL compliance of PET images
por: Pfaehler, Elisabeth, et al.
Publicado: (2022)

Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
por: Cheebsumon, Patsuree, et al.
Publicado: (2012)

The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases
por: Nielsen, Karin, et al.
Publicado: (2014)

Castrations Statistics
por: Adams, W. S.
Publicado: (1883)

Clinical verification of (18)F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer
por: Meijer, Dennie, et al.
Publicado: (2020)

Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies
por: van Velden, Floris H. P., et al.
Publicado: (2011)

Noise sensitivity of (89)Zr-Immuno-PET radiomics based on count-reduced clinical images
por: Somasundaram, Ananthi, et al.
Publicado: (2022)

Potential and pitfalls of (89)Zr-immuno-PET to assess target status: (89)Zr-trastuzumab as an example
por: Huisman, Marc C., et al.
Publicado: (2021)

Early (18)F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer
por: van Helden, Erik J., et al.
Publicado: (2016)

Cylindroma, an uncommon presentation on (18)F-DCFPyL PET/CT
por: Koene, B. P. F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3090lsc5uhdvqi7kagcn47b91b